Ten Berge IJM - Search Results

1

Antibodies against ARHGDIB are associated with long-term kidney graft loss.

Kamburova EG, Gruijters ML, Kardol-Hoefnagel T, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Melchers RCA, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Bemelman FJ, Otten HG. Kamburova EG, et al. Among authors: ten berge ijm. Am J Transplant. 2019 Dec;19(12):3335-3344. doi: 10.1111/ajt.15493. Epub 2019 Jul 3. Am J Transplant. 2019. PMID: 31194283 Free PMC article.

2

Activation of coagulation and fibrinolysis following OKT3 administration to renal transplant recipients: association with distinct mediators.

Raasveld MH, Hack CE, ten Berge IJ. Raasveld MH, et al. Thromb Haemost. 1992 Sep 7;68(3):264-7. Thromb Haemost. 1992. PMID: 1279831

3

Pretreatment with divided doses of steroids strongly decreases side effects of OKT3.

Bemelman FJ, Buysmann S, Surachno J, Wilmink JM, Schellekens PT, ten Berge IJ. Bemelman FJ, et al. Kidney Int. 1994 Dec;46(6):1674-9. doi: 10.1038/ki.1994.467. Kidney Int. 1994. PMID: 7700026 Free article.

4

Expression of granzyme A and B proteins by cytotoxic lymphocytes involved in acute renal allograft rejection.

Kummer JA, Wever PC, Kamp AM, ten Berge IJ, Hack CE, Weening JJ. Kummer JA, et al. Kidney Int. 1995 Jan;47(1):70-7. doi: 10.1038/ki.1995.8. Kidney Int. 1995. PMID: 7731173 Free article.

5

Toxicity of OKT3 increases with dosage: a controlled study in renal transplant recipients.

Parlevliet KJ, Bemelman FJ, Yong SL, Hack CE, Surachno J, Wilmink JM, ten Berge IJ, Schellekens PT. Parlevliet KJ, et al. Transpl Int. 1995;8(2):141-6. doi: 10.1007/BF00344424. Transpl Int. 1995. PMID: 7766296 Clinical Trial.

6

High-affinity cytotoxic T lymphocytes after non-HLA-sharing blood transfusion--the other side of the coin.

van Twuyver E, Mooijaart RJ, ten Berge IJ, van der Horst AR, Wilmink JM, Claas FH, de Waal LP. van Twuyver E, et al. Transplantation. 1994 Apr 27;57(8):1246-51. doi: 10.1097/00007890-199404270-00018. Transplantation. 1994. PMID: 8178352

7

Serum neopterin/creatinine values correlate with severity of symptoms caused by cytomegalovirus infection in renal transplant recipients.

Raasveld MH, Bloemena E, Wertheim-van Dillen P, Surachno J, Wilmink JM, ten Berge IJ. Raasveld MH, et al. Transpl Int. 1993 Jan;6(1):42-4. doi: 10.1007/BF00336639. Transpl Int. 1993. PMID: 8383975

8

Complement activation during OKT3 treatment: a possible explanation for respiratory side effects.

Raasveld MH, Bemelman FJ, Schellekens PT, van Diepen FN, van Dongen A, van Royen EA, Hack CE, ten Berge IJ. Raasveld MH, et al. Kidney Int. 1993 May;43(5):1140-9. doi: 10.1038/ki.1993.160. Kidney Int. 1993. PMID: 8510394 Free article.

9

Activation and increased expression of adhesion molecules on peripheral blood lymphocytes is a mechanism for the immediate lymphocytopenia after administration of OKT3.

Buysmann S, Bemelman FJ, Schellekens PT, van Kooyk Y, Figdor CG, ten Berge IJ. Buysmann S, et al. Blood. 1996 Jan 1;87(1):404-11. Blood. 1996. PMID: 8547669 Free article.

10

CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes.

Wolbink GJ, Brouwer MC, Buysmann S, ten Berge IJ, Hack CE. Wolbink GJ, et al. J Immunol. 1996 Jul 1;157(1):473-9. J Immunol. 1996. PMID: 8683153

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

252 results

Search Page